State Ledger
Company profile

Artiva Biotherapeutics, Inc. CIK 1817241

Ticker
ARTV (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
San Diego, CA 92121
Fiscal year end
2025 (FY)
Market Data
Close
$6.76
Change
-$0.17
Change %
-2.45%
Volume
11,934

ARTV · trading date Oct 12, 2026 · previous close $6.93 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$0
Net income
-$83.87M
Total assets
$130.94M
Total liabilities
$20.97M
Stockholders' equity
$109.97M
Cash & equivalents
$26.70M
Operating income
-$89.81M
Operating cash flow
-$76.75M
Capital expenditures
$2.59M

Fiscal year 2025, via 10-K filed 2026-03-10. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$79.34M
Free cash flow margin
—
Liabilities / assets
16.0%
Equity / assets
84.0%
CapEx / revenue
—
Operating cash flow / net income
0.92×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $0 -$83.87M $130.94M $20.97M $109.97M
2024 $251.0K -$65.37M $209.58M $22.94M $186.64M
2023 $33.49M -$28.72M $105.11M $50.72M -$162.02M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-15
Financials filed via
Form 10-K
filed 2026-03-10

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Diego, CA 92121
5505 MOREHOUSE DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies